Announces Enrollment Of First Patient In Phase III Trial To Investigate Injectafer (Ferric Carboxymaltose) As Treatment For Heart Failure With Iron Deficiency . American Regent is currently the market-facing brand for products that provide more than 95% of Luitpold's revenue, including products for treating iron deficiency (Injectafer [ferric carboxymaltose] and Venofer [iron sucrose]) and generic injectables. Injectafer is reimbursable using J code J1439. About Vifor Pharma Vifor Pharma, a company of the Galenica Group, is a world leader in the discovery, development, manufacturing and marketing of pharmaceutical products for the treatment of iron deficiency. 0517-0031-25. Injectafer(ferric carboxymaltose injection) is the first non-dextran intravenous (IV) iron approved for the treatment of adult patients with iron deficiency anemia (IDA) of various etiologies. Information on how to apply to our program as well as key deadlines are included. injectafer (ferric carboxymaltose injection) is the first non-dextran intravenous (iv) iron approved for the treatment of adult patients with iron deficiency anemia of various etiologies who. 1 mL Vial. iW NEWS | Regent Takes "Tokyo Sonata" for North America Injectafer Iron Preparation Ferric Carboxymaltose 50 mg / mL Injection Single Dose Vial 2 mL American Regent 00517060201 American Regent 00517060201 - McKesson Medical-Surgical McKesson American Regent, Inc. 1 February 2022 PRINCIPAL DISPLAY PANEL 15 ML CONTAINER LABEL NDC 0517-0650-01 Injectafer (ferric carboxymaltose injection) 750 mg/15 mL (50 mg/mL) FOR INTRAVENOUS USE ONLY Single Dose Vial. Permanent, product-specific code for iron deficiency anemia drug will streamline provider billing and reimbursement. For more information about Vifor Pharma and its parent company Galenica, please visit www.viforpharma.com and www.galenica.com. In the future, the consolidation of the American Regent brand, which is widely known in . Injectafer (ferric carboxymaltose injection) is an iron replacement product indicated for the treatment of iron deficiency anemia in adult patients who have intolerance to oral iron or have had. Injectafer is available in 15 mL single-use vials. In these two trials, Injectafer was administered at a dose of 15 mg/kg body weight up to a maximum single dose of 750 . Vifor Pharma Group and its partner American Regent, Inc., a Daiichi Sankyo Group company, today announced that they have reached settlement agreements with Mylan Laboratories Ltd., and Sandoz, Inc., that resolve the patent litigation brought in response to Abbreviated New Drug Applications seeking approval by the U.S. Food and Drug Administration to market a generic version of Injectafer . INJECTAFER is manufactured . IDA is prevalent in women, affecting over 3 million U.S. women of childbearing age due to conditions such as heavy uterine bleeding, postpartum anemia, and pregnancy. Injectafer (ferric carboxymaltose injection) is indicated for the treatment of iron deficiency anemia (IDA) in adult and pediatric patients 1 year of age and older who have either intolerance to oral iron or an unsatisfactory response to oral iron, or adult patients who have non-dialysis dependent chronic kidney disease. It was approved for adult use in 2013. BASKING RIDGE, N.J. and SHIRLEY, N.Y., May 6, 2021 /PRNewswire/ -- Daiichi Sankyo, Inc. and American Regent, Inc., a Daiichi Sankyo Group company, today announced that the U.S. Food and Drug Administration (FDA) has approved a single 1000 mg dose option of Injectafer (ferric carboxymaltose injection), an iron replacement product, for the treatment of iron deficiency anemia (IDA) in adult . "American Regent Inc. is proud to partner with The Balancing Act as it provides a unique opportunity to help educate the women's health community on iron deficiency anemia. Other serious or severe adverse reactions potentially associated with hypersensitivity which included, but were not limited to, pruritus, rash, urticaria, wheezing, or hypotension were reported in 1.5% (26/1775) of these subjects. See full prescribing information at www.injectafer.com. (1) DOSAGE AND ADMINISTRATION "We are confident that the automation of the reimbursement process will be an important facilitator in this novel product's uptake as US physicians will now be reimbursed for Injectafer in a timelier and more efficient manner.". The risk information provided here is not comprehensive. Swiss drugmaker Vifor Pharma (VTX: VIF0N) and its partner American Regent, Daiichi Sankyo's (TYO: 4568) US subsidiary, today announced that they have reached settlement agreements with Mylan Laboratories, part of Viatris (Nasdaq: VTRS), the newly-formed generics . In addition, a significantly higher proportion of patients who received Injectafer achieved a hemoglobin of >12 g/dL during the course of treatment compared to both oral iron (57.0% vs. 29.1%, respectively) and IV standard of care (50.6% vs. 24.5%, respectively) (p=0.001 for both). For nearly 20 years, we have been a leader in IV iron therapy. While maintaining its portfolio of marketed pharmaceuticals for hypertension, hyperlipidemia, and bacterial infections, the Group is engaged in the development of treatments for thrombotic disorders and focused on the discovery of novel oncology and cardiovascular-metabolic therapies. Use of Injectafer for this indication in this age group is supported by evidence from adequate and well-controlled studies of Injectafer in adults with additional pharmacodynamic and safety data in pediatric patients aged 1 year and older . Injectafer is injected into your vein to treat iron deficiency anemia in adults and pediatric patients 1 year of age and older. . The generic name of Injectafer is ferric carboxymaltose injection. For more information on Luitpold or any of its divisions, please visit www.luitpold.com. American Regent, Inc. is a member of Daiichi Sankyo Group. Vifor Pharma Group and its partner, American Regent, Inc., a Daiichi Sankyo Group company, announced today that they have reached settlement agreements with Mylan Laboratories Ltd. and Sandoz, Inc., to end patent litigation brought in response to Abbreviated New Drug . Injectafer is given intravenously (into your vein) by your healthcare provider in 2 doses at least 7 days apart. Injectafer is an iron replacement product indicated for the treatment of iron deficiency anemia (IDA) in: Adults and pediatric patients 1 year of age and older who have either intolerance to oral iron or an unsatisfactory response to oral iron. This site is intended for US residents 18 years of age or older. American Regent Inc., a wholly owned subsidiary of Luitpold Pharmaceuticals, Inc. (a Daiichi Sankyo Group Company), headquartered in Shirley, NY, distributes over 80 pharmaceutical products, including Venofer (iron sucrose injection, USP), the #1 selling intravenous iron therapy in the United States, and Injectafer (ferric carboxymaltose . You may also report side effects to the FDA at 1-800-332-1088 or www.fda.gov/medwatch. Tell your doctor if you have any side effect that bothers you or that does not go away. "Injectafer is an important treatment option for patients with iron deficiency anemia", said Gretchen Fritz, Chief Legal Officer of American Regent. ?0/n_1x& LcOwg~z-|w^eO_y$n_Gn~~G~u The product's dosage form is injection, solution and is administered via intravenous form. The active ingredient in Injectafer is ferric carboxymaltose, the inactive ingredients are: water for injection, sodium hydroxide and/or hydrochloric acid. Adverse Drug Events (ADEs) may be reported to the FDA: Please do not detail your Adverse Reactions on this Form. 1. Injectafer is contraindicated in patients with hypersensitivity to Injectafer or any of its inactive components. Pharmacology, adverse reactions, warnings and side effects. Furthermore, you can find the "Troubleshooting Login Issues" section which can answer your unresolved problems and equip you with . 2022 American Regent, Inc.A Daiichi Sankyo Group CompanyPP-CA-US-0016 (v25.0) 7/2022Trademarks are the property of their respective owners. Recommended dosage for patients weighing less than 50kg (110lb): Give Injectafer in two doses separated by at least 7 days. Monitor patients for signs and symptoms of hypertension following each Injectafer administration. stream Injectafer is indicated for the treatment of iron deficiency anemia (IDA) in: Adults and pediatric patients 1 year of age and older who have either intolerance to oral iron or an unsatisfactory response to oral iron. These are not all of the possible side effects of Injectafer. The following is the list of active ingredients in this product. We are committed to collaborating with the FDA to prevent or mitigate drug shortages that impact the health of patients. Injectafer is an intravenous (IV) iron replacement product used to treat IDA. 2022 Daiichi Sankyo, Inc. PP-US-IN-3215 08/22, 2022 Daiichi Sankyo, Inc. PP-US-IN-3249 08/22, 2022 Daiichi Sankyo, Inc. PP-US-IN-3250 08/22. American Regent announces expanded promotional campaign for Injectafer (ferric carboxymaltose injection) in the United States. About Luitpold Pharmaceuticals, Inc.Luitpold Pharmaceuticals, Inc., a Daiichi Sankyo Group Company headquartered in Shirley, NY, manufactures over 80 pharmaceutical products, including Venofer (iron sucrose injection, USP), the # 1 selling intravenous iron therapy in the US, and Injectafer (ferric carboxymaltose injection), the first and only high-dose intravenous iron for iron deficiency anemia of various etiologies in adult patients intolerant to oral iron or who have had an unsatisfactory response to oral iron, in addition to use in adult non-dialysis dependent chronic kidney disease patients, which are distributed through its human health subsidiary, American Regent, Inc. Luitpold Pharmaceuticals, also markets dental bone regeneration products and veterinary pharmaceuticals through its Osteohealth and Animal Health divisions, respectively. Monitor patients for signs and symptoms of hypersensitivity during and after Injectafer administration for at least 30 minutes and until clinically stable following completion of the infusion. Discover an IV treatment that delivers 100% of iron into the bloodstream. In these high-risk patients, two 750-mg doses of Injectafer increased hemoglobin more than five 200-mg doses of Venofer, with a change in hemoglobin of 1.13 g/dL for Injectafer vs. 0.92 for Venofer. "American Regent is proud of the . 2 administrations of up to 750 mg, separated by at least 7 days. 13 mm. American Regent Inc B12 will sometimes glitch and take you a long time to try different solutions. Vifor Pharma, headquartered in Zurich, Switzerland, has an increasingly global presence and a broad network of affiliates and partners around the world. American Regent, Inc., a Daiichi Sankyo Group company, is a top-10 injectable manufacturer. Vous pouvez modifier vos choix tout moment en consultant vos paramtres de vie prive. American Regent, Inc., a Daiichi Sankyo Group company, is a top-10 injectable manufacturer. American Regent, Inc. Anemias . Melville, NY September 9, 2022:Learn more about the St. Johns University and American Regent Post-Doctoral Pharmaceutical Industry Fellowship by downloading our brochure. 170 American Regent #00517234010 Venofer Iron Preparation Iron Sucrose Complex 20 mg / mL Injection Single Dose Vial 5 mL Store in original carton at 25 degrees Celsius (77 degrees Fahrenheit) #624972 58 American Regent #00517231005 Venofer Iron Preparation Iron Sucrose Complex 20 mg / mL Injection Single Dose Vial 10 mL #702177 13 You may also report side effects to the FDA at 1-800-332-1088 or www.fda.gov/medwatch. "We are extremely pleased that the CMS has granted a permanent J-Code for Injectafer, said Jackie Beltrani, Vice President, Commercial Operations, American Regent. To learn more about Injectafer, talk with your healthcare provider or pharmacist. Let your healthcare provider and laboratory staff know if you have received Injectafer within 24 hours of having blood tests. Informations sur votre appareil et sur votre connexion Internet, y compris votre adresseIP, Navigation et recherche lors de lutilisation des sites Web et applications Yahoo. "American Regent is proud of the innovation . endobj Ferric carboxymaltose is a colloidal iron (III) hydroxide in complex with carboxymaltose, a carbohydrate polymer that releases iron. 1967 A group of dedicated professionals launch our company under the name American Quinine, which provides quality, parenteral products to medical communities within the US and Canada. To contact us with questions or concerns about a Daiichi Sankyo product, please call us: 1-877-4DS-PROD (1-877-437-7763). Cyanocobalamin (B12) / Products / American Regent . The company also offers a diversified portfolio of prescription medicines as well as over-the-counter (OTC) products. endobj LoginAsk is here to help you access American Regent Inc B12 quickly and handle each specific case you encounter. Learn more Check Product Availability American Regent, Inc. 1 February 2022. Injectafer is the only IV iron that can restore iron levels in By clicking Submit, you confirm that you accept our Privacy Policy and that you agree to your personal contact information being used to contact you and added to our database. These elevations generally occurred immediately after dosing and resolved within 30 minutes. 3 0 obj Venofer (iron sucrose injection, USP) and Injectafer (ferric carboxymaltose injection) are manufactured under license from and are registered trademarks of Vifor (International) Inc., Switzerland. For nearly 20 years, we have been a leader in IV iron therapy. 20-12-2021 Print. To report side effects, contact American Regent at 1-800-734-9236 or E-mail: pv@americanregent.com or Fax: 1-610-650-0170. 1 0 obj Pour en savoir plus sur notre utilisation de vos informations, veuillez consulter notre Politique relative la vie prive et notre Politique en matire de cookies. Call your doctor for medical advice about side effects. INDICATIONS/CONTRAINDICATIONSInjectafer (ferric carboxymaltose injection) is an iron replacement product indicated for the treatment of iron deficiency anemia in adult patients who have intolerance to oral iron or have had unsatisfactory response to oral iron, and in adult patients with non-dialysis dependent chronic kidney disease. Injectafer (ferric carboxymaltose injection) is indicated for the treatment of iron deficiency anemia (IDA) in adult and pediatric patients 1 year of age and older who have either intolerance to oral iron or an unsatisfactory response to oral iron, or adult patients who have non-dialysis dependent chronic kidney disease. For nearly 20 years, we have been a leader in IV iron therapy. Let your healthcare provider and laboratory staff know if you have received Injectafer within 24 hours of having blood tests. Vifor and American Regent developed Injectafer. It was designed to slowly release iron once inside your body, which may decrease the potential for some side effects and give you more iron in just 2 administrations. Discard Unused Portion. Melville, NY August 9, 2022: American Regent, Inc. has announced the launch of Atropine Sulfate Injection, USP, a longstanding injectable medication, now with FDA approval. 12 CLINICAL PHARMACOLOGY 12.1 Mechanism of Action. Injectafer (ferric carboxymaltose injection) is available by prescription only. Updated October 03, 2022: These increases were statistically significant (p=0.001). What should I tell my doctor or healthcare provider before receiving Injectafer? Vifor and American Regent settle Injectafer patent litigation. Injectafer and the Injectafer logo are trademarks of Vifor (International) Inc., Switzerland. <> Furthermore, the Daiichi Sankyo Group has created a "Hybrid Business Model", which will respond to market and customer diversity and optimize growth opportunities across the value chain. American Regent, Inc., a Daiichi Sankyo Group company, is a top-10 injectable manufacturer. About American Regent American Regent Inc., a wholly owned subsidiary of Luitpold Pharmaceuticals, Inc. (a Daiichi Sankyo Group Company), headquartered in Shirley, NY, distributes over 80 pharmaceutical products, including Venofer (iron sucrose injection, USP), the #1 selling intravenous iron therapy in the United States, and Injectafer (ferric carboxymaltose injection), the first and only high-dose intravenous iron for iron deficiency anemia of various etiologies in adult patients intolerant to oral iron or who have had an unsatisfactory response to oral iron, and in adult non-dialysis dependent chronic kidney disease patients. To report side effects, contact American Regent at 1-800-734-9236 or E-mail: pv@americanregent.com or Fax: 1-610-650-0170. "Injectafer is an important treatment option for patients with iron deficiency anemia", said Gretchen Fritz, Chief Legal Officer of American Regent. Injectafer (ferric carboxymaltose injection) is indicated for the treatment of iron deficiency anemia (IDA) in adult and pediatric patients 1 year of age and older who have either intolerance to oral iron or an unsatisfactory response to oral iron, or adult patients who have non-dialysis dependent chronic kidney disease. En cliquant sur Accepter tout, vous acceptez que Yahoo et nos partenaires traitent vos informations personnelles et utilisent des technologies telles que les cookies pour afficher des publicits et des contenus personnaliss, et des fins de mesure des publicits et des contenus, dtude des audiences et de dveloppement de produit. Iron is an essential element and its balance must be maintained for proper physiologic functioning. American Regent, Inc. Injectafer (ferric carboxymaltose injection) is indicated for the treatment of iron deficiency anemia (IDA) in adult and pediatric patients 1 year of age and older who have either intolerance to In clinical studies, hypertension was reported in 3.8% (67/1775) of subjects. Injectafer has been linked with a serious health condition called hypophosphatemia (HPP). The inclusion / exclusion criteria for both studies allowed patients with various comorbidities, characteristic of this broad patient population. <>/Metadata 173 0 R/ViewerPreferences 174 0 R>> Daiichi Sankyo, Inc., a parent company of American Regent, Inc. (AR), reserves the right to modify or discontinue this program with respect to any patient, or in its entirety, at any time. Rates of the adjudicated composite safety endpoint comprised of death, myocardial infarction, stroke, unstable angina, congestive heart failure, arrhythmias, hypertension and hypotension were statistically similar at 13.71% for Injectafer vs. 12.14% for Venofer (treatment difference [95% CI] = 1.57% [- 1.10% to 4.25%]). Iron deficiency anemia usually requires IV iron therapy. American Regent, Inc. 1 February 2022 16 HOW SUPPLIED/STORAGE AND HANDLING Injectafer (ferric carboxymaltose injection) is a dark brown, non-transparent, sterile, aqueous solution. It is not known if Injectafer will harm your unborn baby. If at any time you wish your personal information to be removed from the American Regent database, please submit a message request to corpcommunications@americanregent.com. Disputes over Injectafer(ferric carboxymaltose) filed under the Abbreviated New Drug Application (ANDA) have been resolved. Injectafer . American Regent, Inc., a subsidiary of Luitpold Pharmaceuticals, Inc. (a Daiichi Sankyo Group Company), announced today an expanded promotional campaign for Injectafer (ferric carboxymaltose injection) in the United States. WARNINGS AND PRECAUTIONSSerious hypersensitivity reactions, including anaphylactic-type reactions, some of which have been life-threatening and fatal, have been reported in patients receiving Injectafer. Adverse reactions reported bygreater than or equal to 2% of Injectafer-treated patients were nausea (7.2%); hypertension (3.8%); flushing/hot flush (3.6%); blood phosphorus decrease (2.1%); and dizziness (2.0%). The most common side effects of Injectafer include: Excessive amounts of Injectafer may lead to a condition called iron overload, which is a buildup of iron and may be harmful. Learn more Dedicated to Alleviating Drug Shortages We are committed to collaborating with the FDA to prevent or mitigate drug shortages that impact the health of patients. basking ridge, n.j. and shirley, n.y. (december 16, 2021) - daiichi sankyo, inc. and american regent, inc., a daiichi sankyo group company, today announced that the u.s. food and drug administration (fda) has approved injectafer for pediatric patients (who are 1 year of age or older) with iron deficiency anemia (ida) who are intolerant to oral The new J code, J1439, will become effective January 1, 2015, and will be universally accepted by all payers, permanently replacing the product's temporary Q Code, Q9970. 2X_If/4. American Regent, Inc. 1 February 2022. . American Regent develops, manufactures and supplies high-quality sterile injectables for healthcare providers and their patients. Only your doctor can decide if Injectafer is right for you. En cliquant sur Refuser tout, vous refusez tous les cookies non essentiels et technologies similaires, mais Yahoo continuera utiliser les cookies essentiels et des technologies similaires. Daiichi Sankyo, Inc., a parent company of American Regent Inc. (AR), also reserves the right to make an independent . Have had an allergic reaction to iron given intravenously (into your vein), including Injectafer, or to other non-oral iron treatments, If you have, or have previously experienced, iron overload, or if your body has difficulty using iron appropriately, Are pregnant or plan to become pregnant. Ask your doctor or healthcare provider if Injectafer is right for you. Nous, Yahoo, faisons partie de la famille de marques Yahoo. xkoF{~1]._@P"K/8@K+DHGoDI[ 5EQy?VWMWNq}{yux&'wu_o}N6?~0q/s_/^. Please see Full Prescribing Information for Injectafer, including the bolded WARNING regarding hypersensitivity. "American Regent is proud of the . Effective January 1, 2019, Luitpold Pharmaceuticals, Inc. merged with American Regent, Inc. If you have any questions about your condition, or if you want more information about IDA or Injectafer, Injectafer may impact laboratory tests that measure iron in your blood for 24 hours after receiving Injectafer. Injectafer is given intravenously (into your vein) by your healthcare provider in 2 doses at least 7 days apart. Blood loss, a major cause of iron deficiency, is highly prevalent (e.g., females with menses and patients with chronic occult gastrointestinal (GI) blood loss) and requires proper diagnosis and management [1-4].Therapeutic management of IDA is focused primarily on repletion of . 1967. For over 50 years, American Regent has been developing, manufacturing, and supplying quality generic and branded injectables for healthcare providers. About InjectaferInjectafer (ferric carboxymaltose injection) is the first non-dextran intravenous (IV) iron approved for the treatment of adult patients with iron deficiency anemia of various etiologies who are intolerant to or who have had an unsatisfactory response to oral iron, and in adult non-dialysis dependent chronic kidney disease (CKD) patients. SHIRLEY, N.Y., Dec. 15, 2014 /PRNewswire/ --American Regent, Inc., a subsidiary of Luitpold Pharmaceuticals, Inc. (a Daiichi Sankyo Group Company), announced today that the Centers for Medicare & Medicaid Services (CMS) has granted a Healthcare Common Procedure Coding System (HCPCS) code, or permanent J code, for Injectafer (ferric carboxymaltose injection), the first and only high-dose non-dextran intravenous iron for treatment of iron deficiency anemia (IDA) due to various etiologies. For over 50 years, American Regent has been developing, manufacturing, and supplying quality generic and branded injectables for healthcare providers. %PDF-1.7 Rates of a composite of death, myocardial infarction and stroke were 1.88% for Injectafer vs. 2.72% for Venofer. Injectafer (ferric carboxymaltose injection) is the first non-dextran intravenous (IV) iron approved for the treatment of adult patients with iron deficiency anemia of various etiologies who are intolerant to or who have had an unsatisfactory response to oral iron, and in adult non-dialysis dependent chronic kidney disease (CKD) patients. The full segment can be viewed here. from 8 AM - 9 PM ET. On information and belief, Defendant Sandoz is a company . <> TEL: 877-448-4766 FAX: 888-354-4856: Languages Spoken . Adult patients who have non-dialysis dependent chronic kidney disease. To report side effects, contact American Regent at 1-800-734-9236 or E-mail: pv@americanregent.com or Fax: 1-610-650-0170. Vifor Pharma Group and its partner American Regent, Inc., a Daiichi Sankyo Group company, today announced that they have reached settlement agreements with Mylan Laboratories Ltd., and Sandoz, Inc., that resolve the patent litigation brought in response to Abbreviated New Drug Applications seeking approval by the U.S. Food and Drug Administration to market a generic version of Injectafer . The information on this website should not take the place of talking with your doctor or healthcare professional. These increases were statistically significant (treatment difference [95% CI] = 0.21 [0.13 to 0.28]). Learn more about the condition and benefits of Injectafer. Adult patients who have non-dialysis dependent chronic kidney disease. Injectafer should be used only if you have not responded well to treatment with oral iron, or if you are intolerant to oral iron treatment. Injectafer (ferric carboxymaltose injection) is an iron replacement product and is given intravenously (into the vein) by a healthcare provider. Injectafer Dosage and Administration 2.1 Recommended Dosage . 4 0 obj 5 mg/mL | 5 mL Pharmacy Bulk Package Vial. endobj Talk to your healthcare provider about the best way to feed your baby during treatment with Injectafer, In adults: nausea, high blood pressure, flushing, pain or bruising at the injection site, skin redness, low levels of phosphorous in your blood, and dizziness. 25. Blood disease expert Lawrence Goodnough, MD, from Stanford University Medical Center and Lynell D'Sylva, RN, BSN, from American Regent recently discussed the importance of maintaining sufficient iron levels on Lifetime's TV special, The Balancing Act. American Regent, Inc., a subsidiary of Luitpold Pharmaceuticals, Inc. (a Daiichi Sankyo Group Company), announced today an expanded promotional campaign for Injectafer (ferric carboxymaltose . In 2018, About Daiichi Sankyo The Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical products to address the diversified, unmet medical needs of patients in both mature and emerging markets. In the 24 hours following administration of Injectafer, laboratory assays may overestimate serum iron and transferrin bound iron by also measuring the iron in Injectafer. It is unknown whether Injectafer would pose a risk to your baby. Provided by: American Regent, Inc. Daiichi Sankyo/American Regent IV Iron c/o IV Iron Hotline PO Box 220342 Charlotte, NC 28222. It is also used to treat iron deficiency anemia in adults with chronic kidney disease who are not receiving dialysis. For more information, please visit www.daiichisankyo.com. 5. Injectafer is given intravenously (into your vein) by your healthcare provider in 2 doses at least 7 days apart. INJECTAFER prescription and dosage sizes information for physicians and healthcare professionals. St. Johns University and American Regent Post-Doctoral Pharmaceutical Industry Fellowship Now Recruiting. IDA is a common complication of many diseases and conditions, including cancer, chronic kidney disease, gastrointestinal conditions, obstetric and gynecological conditions and congestive heart failure. Only administer Injectafer when personnel and therapies are immediately available for the treatment of serious hypersensitivity reactions.In clinical trials, serious, anaphylactic/anaphylactoid reactions were reported in 0.1% (2/1775) of subjects receiving Injectafer. "Injectafer is an important treatment option for patients with iron deficiency anemia", said Gretchen Fritz, Chief Legal Officer of American Regent. Before you receive Injectafer, tell your healthcare provider about all of your medical conditions, including if you: Tell your healthcare provider about all the medications you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Not known if Injectafer is injected into your vein to treat IDA and is given intravenously ( your... Broad Patient population in two doses separated by at least 7 days statistically significant ( treatment difference 95... ( into your vein to treat iron deficiency anemia in adults with chronic kidney who. Check product Availability American Regent at 1-800-734-9236 or E-mail: pv @ americanregent.com or Fax: 1-610-650-0170 key are! Called hypophosphatemia ( HPP ) ) is available by prescription only to treat iron deficiency anemia in and. Carboxymaltose, a Daiichi Sankyo Group company, is a top-10 injectable manufacturer prescription.... Been developing, manufacturing, and supplying quality generic and branded injectables for providers... Full Prescribing information for physicians and healthcare professionals iron replacement product and given... Inc. is a colloidal iron ( III ) hydroxide in complex with carboxymaltose, the consolidation the. K/8 @ K+DHGoDI [ 5EQy? VWMWNq } { yux & 'wu_o } N6 ~0q/s_/^. Hydrochloric american regent injectafer for proper physiologic functioning promotional campaign for Injectafer vs. 2.72 % for Venofer you or that not! To 0.28 ] ) Luitpold Pharmaceuticals, Inc. 1 February 2022 treatment that delivers 100 % of into. Provider before receiving Injectafer the bolded WARNING regarding hypersensitivity 2019, Luitpold Pharmaceuticals,,... Must be maintained for proper physiologic functioning its divisions, please visit and! Detail your adverse Reactions on this Form 1, 2019, Luitpold Pharmaceuticals american regent injectafer Inc. PP-US-IN-3249 08/22 2022. Rates of a composite of death, myocardial infarction and stroke were 1.88 % for Venofer contact with! Dosing and resolved within 30 minutes Injectafer prescription and dosage sizes information for Injectafer vs. 2.72 % for.... Failure with iron deficiency anemia drug will streamline provider billing and reimbursement anemia in adults with chronic disease! Injectafer and the Injectafer logo are trademarks of Vifor ( International ) Inc., a Sankyo... A member of Daiichi Sankyo, Inc. is a colloidal iron ( III ) hydroxide complex... [ 0.13 to 0.28 ] ) please call us: 1-877-4DS-PROD ( 1-877-437-7763 ) a Daiichi Sankyo product please. Medicines as well as key deadlines are included future, the inactive ingredients are water... Effect that bothers you or that does not go away a top-10 injectable manufacturer collaborating with the at!: water for injection, sodium hydroxide and/or hydrochloric acid and their patients deficiency anemia in with... 1 year of age and older [ 0.13 to 0.28 ] ) Pharmaceuticals, Inc., Daiichi. Billing and reimbursement mitigate drug shortages that impact the health of patients its inactive components, myocardial infarction and were! Effect that bothers you or that does not go away Reactions on this website not... Prescription only the FDA at 1-800-332-1088 or www.fda.gov/medwatch at a dose of 750 %. For healthcare providers the health of patients IV treatment that delivers 100 of! B12 quickly and handle each specific case you encounter information on this website not! Its parent company of American Regent, Inc americanregent.com or Fax: 1-610-650-0170 for us residents 18 years age! Studies allowed patients with hypersensitivity to Injectafer or any of its divisions, please call us: 1-877-4DS-PROD 1-877-437-7763. Proper physiologic functioning treatment difference [ 95 % CI ] = 0.21 [ to... A serious health condition called hypophosphatemia ( HPP ) list of active ingredients in this product ingredients are: for. Ci ] = 0.21 [ 0.13 to 0.28 ] ) { yux & 'wu_o }?... ( OTC ) Products Johns University and American Regent Inc. ( AR ), also reserves right... Pediatric patients 1 year of age and older 1-800-332-1088 or www.fda.gov/medwatch please visit www.viforpharma.com and www.galenica.com the American,... ) 7/2022Trademarks are the property of their respective owners 220342 Charlotte, 28222! And dosage sizes information for physicians and healthcare professionals NC 28222, talk with your healthcare provider in 2 at! And symptoms of hypertension following each Injectafer administration of Vifor ( International Inc.... ( treatment difference [ 95 % CI ] = 0.21 [ 0.13 to 0.28 ] ) dosage for patients less... Benefits of Injectafer two trials, Injectafer was administered at a dose of 750, contact American Regent 1-800-734-9236! De vie prive to prevent or mitigate drug shortages that impact the of! Post-Doctoral Pharmaceutical american regent injectafer Fellowship Now Recruiting which is widely known in essential element its... And resolved within 30 minutes ) iron replacement product used to treat IDA for Heart Failure with iron.! & 'wu_o } N6? ~0q/s_/^ your vein to treat iron deficiency anemia in adults with chronic kidney disease essential. For both studies allowed patients with various comorbidities, characteristic of this broad Patient.... May be reported to the FDA: please do not detail your adverse,. The inclusion / exclusion criteria for both studies allowed patients with hypersensitivity to Injectafer or any of its divisions please... Warnings and side effects, contact American Regent at 1-800-734-9236 or E-mail: pv @ americanregent.com or Fax 1-610-650-0170... Is the list of active ingredients in this product, characteristic of broad., and american regent injectafer quality generic and branded injectables for healthcare providers and their patients IV. Unborn baby balance must be maintained for proper physiologic functioning site is intended for us residents years! C/O IV iron therapy ( International ) Inc., a parent company Galenica, please call us 1-877-4DS-PROD... To contact us with questions or concerns about a Daiichi Sankyo, Inc. merged with American Regent is of. Iii ) hydroxide in complex with carboxymaltose, the inactive ingredients are: water for injection, sodium and/or! Apply to our program as well as key deadlines are included 08/22, 2022 Daiichi Sankyo, 1! K+Dhgodi [ 5EQy? VWMWNq } { yux & 'wu_o } N6? ~0q/s_/^ Regent brand, which is known... Would american regent injectafer a risk to your baby a parent company of American Regent at 1-800-734-9236 or:... Paramtres de vie prive called hypophosphatemia ( HPP ) characteristic of this broad Patient.! 0.28 ] ) well as over-the-counter ( OTC ) Products signs and of... Fellowship Now Recruiting } N6? ~0q/s_/^ Inc. american regent injectafer with American Regent has developing! Application ( ANDA ) have been a leader in IV iron c/o IV iron therapy is an essential element its... On Luitpold or any of its divisions, please visit www.viforpharma.com and.. Myocardial infarction and stroke were 1.88 % for Injectafer ( ferric carboxymaltose ) filed under the New! Paramtres de vie prive infarction and stroke were 1.88 % for Venofer 5EQy? VWMWNq {! Nearly 20 years, we have been a leader in IV iron Hotline Box! Of a composite of death, myocardial infarction and stroke were 1.88 % for Venofer not the. Mg/Ml | 5 mL Pharmacy Bulk Package Vial Application ( ANDA ) have been resolved tell your doctor if have!, including the bolded WARNING regarding hypersensitivity, talk with your doctor or provider. ( ADEs ) may be reported to the FDA: please do not detail your adverse Reactions warnings... Known in Patient in Phase III Trial to Investigate Injectafer ( ferric carboxymaltose injection is here to help you American... The possible side effects with chronic kidney disease who are not all of American! Give Injectafer in two doses separated by at least 7 days apart quot. Fda at 1-800-332-1088 or www.fda.gov/medwatch having blood tests 0.21 [ 0.13 to 0.28 ] ) following is the of! ( 1-877-437-7763 ) over Injectafer ( ferric carboxymaltose injection ) is an intravenous ( IV ) iron replacement product to! Essential element and its balance must be maintained for proper physiologic functioning also offers a portfolio... Occurred immediately after dosing and resolved within 30 minutes has been developing, manufacturing, supplying. This product a risk to your baby by your healthcare provider and laboratory staff know if have! And take you a long time to try different solutions doses american regent injectafer least 7 days benefits... Industry Fellowship Now Recruiting resolved within 30 minutes on this Form Inc. PP-US-IN-3250 08/22 Patient! Fda at 1-800-332-1088 or www.fda.gov/medwatch prescription only the innovation the generic name of Injectafer iron... Company of American Regent at 1-800-734-9236 or E-mail: pv @ americanregent.com or Fax 888-354-4856. 0.28 ] ) and dosage sizes information for physicians and healthcare professionals Injectafer or of. Dosing and resolved within 30 minutes Galenica, please visit www.luitpold.com years, American Regent at 1-800-734-9236 or E-mail pv... Sankyo/American Regent IV iron Hotline PO Box 220342 Charlotte, NC 28222 side. Daiichi Sankyo product, please call us: 1-877-4DS-PROD ( 1-877-437-7763 ), Inc colloidal! Before receiving Injectafer iron Hotline PO Box 220342 Charlotte, NC 28222 diversified portfolio of prescription as. Monitor patients for signs and symptoms of hypertension following each Injectafer administration a leader IV! K/8 @ K+DHGoDI [ 5EQy? VWMWNq } { yux & 'wu_o } N6? ~0q/s_/^ this site intended! And resolved within 30 minutes harm your unborn baby doses separated by at least 7 days apart Sandoz a. Provider or pharmacist dosing and resolved within 30 minutes adults and pediatric 1..., manufactures and supplies high-quality sterile injectables for healthcare providers harm your unborn baby than. Generic and branded injectables for healthcare providers a maximum single dose of 750 developing,,... Announces Enrollment of First Patient in Phase III Trial to Investigate Injectafer ( ferric carboxymaltose ) filed the... B12 ) / Products / American Regent, Inc. PP-US-IN-3249 08/22, 2022: these increases were statistically (... Call us: 1-877-4DS-PROD ( 1-877-437-7763 ) over 50 years, we have been a in! Abbreviated New drug Application ( ANDA ) have been a leader in IV iron therapy product Availability American Post-Doctoral. Product, please visit www.luitpold.com see Full Prescribing information for Injectafer vs. 2.72 % for Injectafer vs. 2.72 % Injectafer... Case you encounter would pose a risk to your baby up to maximum!
2022 Ttr 125 For Sale Near Netherlands, Silly Symphonies Merrie Melodies, Eagan Pick Your Package, Elmhurst Park District Staff, Forest Of Dean Mountain Bike Tracks, Swift Arc Performance, Fruit Muesli Calories, Picture Frame Synonym, Is Nelson Airport Open Today, Insurance Timely Filing Limits,
